The above chart listing is from a Pfizer-BioNTech document obtained via FOIA, showing the IgG binding results of a few of the C4591001 human test subjects for the company's "flagship" COVID-19 "vaccine", BNT162b2. The document was given to the FDA on 19 September 2020. BNT162b2 was granted the initial EUA for use in the United … Continue reading The COVID-19 “Vaccines” Pave the Way for Turbo-Cancers: And a Note on the Virus Itself